A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

Summary

The purpose of this study is to evaluate the effect of short-term treatment with darolutamide on breast cancer cells (i.e., how the treatment may change the genes or proteins in breast cancer cells) and to evaluate its safety and the way it is tolerated by subjects. The intent is to study these changes in order to have a better understanding of the potential use of darolutamide for women with EBC, know which patients are likely or unlikely to respond to this treatment, and determine how darolutamide may be combined with other anti-cancer drugs.

Timeline

Start

2017-09-05

Primary completion

2019-02-14

Completion

2019-03-13

Drugs

Indications